Clinical trials
Phase 2/3 Hepatitis C trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 6 |
| 2014 | 3 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2023 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
| Unknown status | 5 |
| Terminated | 3 |
| Withdrawn | 2 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 6 |
| Merck Sharp & Dohme LLC | 3 |
| University of Texas Southwestern Medical Center | 2 |
| White River Junction Veterans Affairs Medical Center | 2 |
| Aga Khan University | 1 |
| BioGeneric Pharma | 1 |
| Biocad | 1 |
| Centers for Disease Control and Prevention | 1 |
| Drugs for Neglected Diseases | 1 |
| Egyptian Liver Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis C | 37 |
| Hepatitis C, Chronic | 11 |
| HIV Infections | 4 |
| Hepatitis | 3 |
| Acquired Immunodeficiency Syndrome | 2 |
| Stress Disorders, Post-Traumatic | 2 |
| Carcinoma | 1 |
| Carcinoma, Hepatocellular | 1 |
| Cryoglobulinemia | 1 |
| Fibrosis | 1 |
Trials
Showing 26 to 37 of 37. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.